Xencor

News

PRESS RELEASES

• 6.29.2009:
  Xencor Appoints Jeffrey V. Ravetch of The Rockefeller University to its Scientific Advisory Board

PUBLICATIONS

• Zalevsky J, Leung IW, Karki S, Chu SY, Zhukovsky EA, Desjarlais JR, Carmichael DF, Lawrence CE (2009)
  The impact of Fc engineering on an anti-CD19 antibody: increased Fc gamma receptor affinity enhances B-cell clearing in nonhuman primates. Blood 113:3735-3743

ARTICLES

• The Pink Sheet
  Xencor to Spruce Up Pfizer Antibodies

EVENTS

• 8.3.2009 – 8.5.2009
  The Next Wave of Antibody Therapeutics
  John Desjarlais, Ph.D., presenting; Boston, MA